Log In
Sunday 23rd October 2016

US firm to open DNA factory

10th April 2007

A company based in Cambridge, Massachusetts is developing a new way of manufacturing component DNA strands which could soon change the face of molecular biology, it says.


Codon Devices was founded with the emergence in 2005 of synthetic biology, out of the recognition that scientists' ability to make complex genetic constructs would be greatly furthered by the availability of DNA strands in made-to-order "kit" form.

It has already created what it believes was the biggest piece of man-made DNA incorporating several genes needed to synthesise a pharmaceutical compound.

Potential applications for Codon's products range from pharmaceuticals, to energy, to agriculture.

Harvard genetics professor George Church, one of Codon's founders, said he expected that genetically engineered cells would be manufactured in the next few years with the capability to deliver drugs or create cellular sensors.

While DNA synthesis is still too expensive to replace more-traditional molecular-biology methods on a broad scale, experts say the DNA-synthesis market is about to boom, much as the DNA-sequencing market has in the past few years.

Codon is confident enough about future prospects to be planning to open a DNA mass-production facility scheduled to open in summer 2007.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016